David N Louis1, Ken Aldape2, Daniel J Brat3, David Capper4,5, David W Ellison6, Cynthia Hawkins7, Werner Paulus8, Arie Perry9, Guido Reifenberger10, Dominique Figarella-Branger11, Pieter Wesseling12,13, Tracy T Batchelor14, J Gregory Cairncross15, Stefan M Pfister16, Stefan Rutkowski17, Michael Weller18, Wolfgang Wick19, Andreas von Deimling4,5. 1. Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 2. Department of Pathology, Princess Margaret Hospital, Toronto, Canada. 3. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA. 4. Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany. 5. Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. 6. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN. 7. Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada. 8. Institute of Neuropathology, University Hospital Munster, Munster, Germany. 9. Department of Pathology, University of California San Francisco, San Francisco, CA. 10. Department of Neuropathology, Heinrich Heine University, Duesseldorf, and German Cancer Consortium (DKTK) partner site, Essen/Duesseldorf, Germany. 11. Department of Pathology and Neuropathology, La Timone Hospital, Aix Marseille University, Marseille, France. 12. Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands. 13. Department of Pathology, Princess Máxima Center for Pediatric Oncology and University Medical Center Utrecht, Utrecht, the Netherlands. 14. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 15. Department of Clinical Neurosciences, University of Calgary, Calgary, Canada. 16. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) Core Center Heidelberg, Heidelberg, Germany; Department of Pediatric Oncology, Hematology, & Immunology, Heidelberg University Hospital, Heidelberg, Germany. 17. Department of Pediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 18. Department of Neurology, University Hospital Zürich, Zürich, Switzerland. 19. Neurology Clinic and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK) Core Center Heidelberg, Heidelberg, Germany.
Authors: Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller Journal: Acta Neuropathol Date: 2018-09-26 Impact factor: 17.088
Authors: David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer Journal: Neuro Oncol Date: 2018-01-22 Impact factor: 12.300
Authors: Dorothee Hölzl; Georg Hutarew; Barbara Zellinger; Hans U Schlicker; Christoph Schwartz; Peter A Winkler; Karl Sotlar; Theo F J Kraus Journal: J Cancer Res Clin Oncol Date: 2021-05-08 Impact factor: 4.553
Authors: David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison Journal: Neuro Oncol Date: 2021-08-02 Impact factor: 13.029